A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease - Daoussis, D; Melissaropoulos, K; Sakellaropoulos, G (Semin Arthritis Rheum, 2017)
, et al.